Gene · 94
Papers4,014
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 4,014
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human liver single nuclear RNA sequencing implicates BMPR2, GDF15, arginine, and estrogen in portopulmonary hypertension. | Commun Biol | 2023 | 37558836 | PubTator, text mining | PubMed |
| Nonfunctional TGF-β/ALK1/ENG signaling pathway supports neutrophil proangiogenic activity in hereditary hemorrhagic telangiectasia. | J Leukoc Biol | 2023 | 37555392 | PubTator, text mining | PubMed |
| Tight junction disruption and the pathogenesis of the chronic complications of diabetes mellitus: A narrative review. | World J Diabetes | 2023 | 37547580 | PubTator, text mining | PubMed |
| Larynx myofibroblastic tumor, a rare case report. | Clin Case Rep | 2023 | 37546157 | PubTator, text mining | PubMed |
| Mediastinal large B cell lymphoma and surrounding gray areas: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology. | Virchows Arch | 2023 | 37530791 | PubTator, text mining | PubMed |
| LRG1 Associates with Iron Deficiency Anemia Markers in Adolescents. | Nutrients | 2023 | 37513518 | PubTator, text mining | PubMed |
| Low-Dose Non-Targeted Effects and Mitochondrial Control. | Int J Mol Sci | 2023 | 37511215 | PubTator, text mining | PubMed |
| CD10-Bound Human Mesenchymal Stem/Stromal Cell-Derived Small Extracellular Vesicles Possess Immunomodulatory Cargo and Maintain Cartilage Homeostasis under Inflammatory Conditions. | Cells | 2023 | 37508489 | PubTator, text mining | PubMed |
| Small Leucine-Rich Proteoglycan PODNL1 Identified as a Potential Tumor Matrix-Mediated Biomarker for Prognosis and Immunotherapy in a Pan-Cancer Setting. | Curr Issues Mol Biol | 2023 | 37504302 | PubTator, text mining | PubMed |
| Addition of heparin binding sites strongly increases the bone forming capabilities of BMP9 in vivo. | Bioact Mater | 2023 | 37502679 | PubTator, text mining | PubMed |
| Nucleosome retention by histone chaperones and remodelers occludes pervasive DNA-protein binding. | Nucleic Acids Res | 2023 | 37493599 | PubTator, text mining | PubMed |
| Portopulmonary Hypertension: An Updated Review. | Transplant Direct | 2023 | 37492078 | PubTator, text mining | PubMed |
| Recent Updates on Viral Oncogenesis: Available Preventive and Therapeutic Entities. | Mol Pharm | 2023 | 37486263 | PubTator, text mining | PubMed |
| An Update on Embolization for Pulmonary Arteriovenous Malformations. | Interv Radiol (Higashimatsuyama) | 2023 | 37485484 | PubTator, text mining | PubMed |
An analysis of sex differences in pulmonary arteriovenous malformation presentation, complications and management in a large, multinational registry of patients with hereditary haemorrhagic telangiectasia. | ERJ Open Res | 2023 | 37483279 | PubTator, text mining | PubMed |
| Unraveling the epigenetic landscape of pulmonary arterial hypertension: implications for personalized medicine development. | J Transl Med | 2023 | 37461108 | PubTator, text mining | PubMed |
| Activin receptor-like kinase 3: a critical modulator of development and function of mineralized tissues. | Front Cell Dev Biol | 2023 | 37457289 | PubTator, text mining | PubMed |
| Delineation of the phenotypes and genotypes of facial infiltrating lipomatosis associated with PIK3CA mutations. | Orphanet J Rare Dis | 2023 | 37452404 | PubTator, text mining | PubMed |
| Hepatic inflammatory myofibroblastic tumor: A case report. | World J Clin Cases | 2023 | 37449218 | PubTator, text mining | PubMed |
| Hereditary hemorrhagic telangiectasia in a 42-year-old Ethiopian man presenting with severe anemia and high-output heart failure: A case report with literature review. | Clin Case Rep | 2023 | 37448947 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/94/papers?page=18